Lixte Stock Overlap Studies PARABOLIC SAR EXTENDED

LIXT -  USA Stock  

USD 2.75  0.07  2.48%

Lixte Biotech overlap studies tool provides the execution environment for running the PARABOLIC SAR EXTENDED study and other technical functions against Lixte Biotech. Lixte Biotech value trend is the prevailing direction of the price over some defined period of time. The concept of trend is an important idea in technical analysis, including the analysis of overlap studies indicators. As with most other technical indicators, the PARABOLIC SAR EXTENDED study function is designed to identify and follow existing trends. Lixte Biotech overlay technical analysis usually involve calculating upper and lower limits of price movements based on various statistical techniques.
Symbol
Refresh

PARABOLIC SAR EXTENDED. The output start index for this execution was zero with a total number of output elements of zero. View also all equity analysis or get more info about parabolic sar extended overlap studies indicator.

Lixte Biotech Technical Analysis Modules

Most technical analysis of Lixte Biotech help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Lixte from various momentum indicators to cycle indicators. When you analyze Lixte charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Lixte Biotech Predictive Technical Analysis

Predictive technical analysis modules help investors to analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Lixte Biotech Hlds. We use our internally-developed statistical techniques to arrive at the intrinsic value of Lixte Biotech Hlds based on widely used predictive technical indicators. In general, we focus on analyzing Lixte Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Lixte Biotech's daily price indicators and compare them against related drivers, such as overlap studies and various other types of predictive indicators. Using this methodology combined with a more conventional technical analysis and fundamental analysis, we attempt to find the most accurate representation of Lixte Biotech's intrinsic value. In addition to deriving basic predictive indicators for Lixte Biotech, we also check how macroeconomic factors affect Lixte Biotech price patterns. Please read more on our technical analysis page or use our predictive modules below to complement your research.
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Lixte Biotech's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Lixte Biotech in the context of predictive analytics.
Hype
Prediction
LowEstimated ValueHigh
0.142.757.17
Details
Intrinsic
Valuation
LowReal ValueHigh
0.122.386.80
Details
Naive
Forecast
LowNext ValueHigh
0.052.697.11
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
2.592.953.31
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Lixte Biotech. Your research has to be compared to or analyzed against Lixte Biotech's peers to derive any actionable benefits. When done correctly, Lixte Biotech's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Lixte Biotech Hlds.

Be your own money manager

As an individual investor, you need to find a reliable way to track all your investment portfolios' performance accurately. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing you full analytical transparency into your positions, our tools can tell you how much better you can do without increasing your risk or reducing expected return.

Generate Optimal Portfolios

Align your risk and return expectations

Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
Additionally, see Stocks Correlation. Note that the Lixte Biotech Hlds information on this page should be used as a complementary analysis to other Lixte Biotech's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.

Complementary Tools for Lixte Stock analysis

When running Lixte Biotech Hlds price analysis, check to measure Lixte Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lixte Biotech is operating at the current time. Most of Lixte Biotech's value examination focuses on studying past and present price action to predict the probability of Lixte Biotech's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Lixte Biotech's price. Additionally, you may evaluate how the addition of Lixte Biotech to your portfolios can decrease your overall portfolio volatility.
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Go
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Go
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Go
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Go
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Go
Fundamental Analysis
View fundamental data based on most recent published financial statements
Go
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Go
The market value of Lixte Biotech Hlds is measured differently than its book value, which is the value of Lixte that is recorded on the company's balance sheet. Investors also form their own opinion of Lixte Biotech's value that differs from its market value or its book value, called intrinsic value, which is Lixte Biotech's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Lixte Biotech's market value can be influenced by many factors that don't directly affect Lixte Biotech Hlds underlying business (such as pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Lixte Biotech's value and its price as these two are different measures arrived at by different means. Investors typically determine Lixte Biotech value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Lixte Biotech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.